Guardant Health, Inc. (GH)

業務介紹

衛安健康公司(Guardant Health, Inc.)是一家精準腫瘤學公司,在美國和國際上提供血液檢測、數據集和分析。該公司提供Guardant360、Guardant360 LDT、Guardant360 CDx和GuardantOMNI液體活檢檢測,用於晚期癌症;以及GuardantINFORM,這是一個基於臨床基因組的液體活檢數據集的in-silico研究平台。該公司還正在開發LUNAR-2檢測,用於無症狀個人的早期結腸直腸癌檢測;以及GuardantConnect,這是一個集成的基於軟件的解決方案,為尋求將使用Guardant360檢測的患者與潛在相關臨床試驗相連的臨床和生物製藥客戶。此外,該公司還提供Guardant Reveal Test,用於早期癌症患者的新輔助和輔助治療選擇;Guardant360組織基因分型產品;以及Guardant-19,用於檢測新型冠狀病毒。此外,該公司還提供開發服務,包括伴隨診斷開發和監管批准、臨床研究設置、監測和維護、檢測開發和支持以及套件履行相關服務,面向生物製藥公司和醫療機構。該公司成立於2011年,總部位於加利福尼亞州雷德伍德城。



Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

公司網址

https://guardanthealth.com